Effective Practices for Treating Patients with CLL During the COVID-19 Era and Beyond
Javier Munoz, MD, MS, MBA, FACP, Senior Associate Consultant, Division of Hematology and Medical Oncology
Mayo Clinic Arizona
The ongoing COVID-19 pandemic deeply affected the treatment patterns for patients with chronic lymphocytic leukemia (CLL). Hear what providers may face when seeing patients with CLL whose disease may have been poorly monitored due to COVID-19 restrictions. Discuss effective practices for treating patients with CLL during the pandemic—including best options and timing for treatment and any changes to the usual treatment regimen. Explore what care may look like for patients with CLL now and beyond the pandemic and learn strategies to prepare for the future and improve the care of this patient population.
This session is not offered for Continuing Education credit hours.